GCCs in India have witnessed a paradigm shift in terms of their maturity curve graduating from simply being looked up to as a ...

Just two weeks into 2025, January is proving why it’s earned a reputation as the worst month for layoffs. | Just two weeks ...

The pharmaceutical landscape enters 2025 with a mix of challenges and opportunities, with the potential to shape the future ...

India's richest families, including the Ambani family, Adani family, and others like Shiv Nadar and Dilip Shanghvi, have ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Join the Government of Assam and FICCI in Mumbai on January 6, 2025, for an exclusive Roadshow showcasing Assam's economic growth and investment opportunities. Led by Chief Minister Dr. Himanta Biswa ...

Look for renewed investment driven by lower interest rates in the new year, and a continued focus on late-stage assets, ...

Sudarshan Jain, Secretary General, Indian Pharmaceutical Alliance maintained that the Indian pharmaceutical industry is at a ...

The state-sponsored hackers stole unclassified documents during the raid, but little else is known about what they accessed.

Eli Lilly and Company has invested more than $20 billion in its manufacturing capabilities since 2020 to help meet high ...

The Australian Government has announced the ‘2024 Clinical Trial Enabling Infrastructure’ grant opportunity, offering A$35.7m for research.